JP2010512326A5 - - Google Patents

Download PDF

Info

Publication number
JP2010512326A5
JP2010512326A5 JP2009540329A JP2009540329A JP2010512326A5 JP 2010512326 A5 JP2010512326 A5 JP 2010512326A5 JP 2009540329 A JP2009540329 A JP 2009540329A JP 2009540329 A JP2009540329 A JP 2009540329A JP 2010512326 A5 JP2010512326 A5 JP 2010512326A5
Authority
JP
Japan
Prior art keywords
protein
stable
sequence
seq
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009540329A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010512326A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/025180 external-priority patent/WO2008073351A2/en
Publication of JP2010512326A publication Critical patent/JP2010512326A/ja
Publication of JP2010512326A5 publication Critical patent/JP2010512326A5/ja
Pending legal-status Critical Current

Links

JP2009540329A 2006-12-08 2007-12-10 Cerberus、Cocoおよびこれらの誘導体の使用 Pending JP2010512326A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87393306P 2006-12-08 2006-12-08
PCT/US2007/025180 WO2008073351A2 (en) 2006-12-08 2007-12-10 Uses of cerberus, coco and derivatives thereof

Publications (2)

Publication Number Publication Date
JP2010512326A JP2010512326A (ja) 2010-04-22
JP2010512326A5 true JP2010512326A5 (cg-RX-API-DMAC7.html) 2011-03-10

Family

ID=39183158

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009540329A Pending JP2010512326A (ja) 2006-12-08 2007-12-10 Cerberus、Cocoおよびこれらの誘導体の使用

Country Status (6)

Country Link
US (2) US7833971B2 (cg-RX-API-DMAC7.html)
EP (1) EP2099471A2 (cg-RX-API-DMAC7.html)
JP (1) JP2010512326A (cg-RX-API-DMAC7.html)
AU (1) AU2007332819A1 (cg-RX-API-DMAC7.html)
CA (1) CA2671983A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008073351A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9045553B2 (en) * 2004-05-27 2015-06-02 Acceleron Pharma, Inc. Cerberus/Coco derivatives and uses thereof
WO2016164089A2 (en) 2015-04-06 2016-10-13 Acceleron Pharma Inc. Tgf-beta superfamily type i and type ii receptor heteromultimers and uses thereof
MA41919A (fr) 2015-04-06 2018-02-13 Acceleron Pharma Inc Hétéromultimères alk4:actriib et leurs utilisations
WO2017177013A1 (en) * 2016-04-06 2017-10-12 Acceleron Pharma Inc. Alk7 antagonists and uses thereof
RS62011B1 (sr) 2016-07-15 2021-07-30 Acceleron Pharma Inc Kompozicije koje sadrže polipeptide actriia za upotrebu u lečenju plućne hipertenzije
KR20190075078A (ko) 2016-10-05 2019-06-28 악셀레론 파마 인코포레이티드 ALK4:ActRIIB 이형다량체 및 이의 용도
WO2022098812A1 (en) 2020-11-04 2022-05-12 Keros Therapeutics, Inc. Methods of treating iron overload

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133232A (en) 1996-06-20 2000-10-17 The Regents Of The University Of California Endoderm, cardiac and neural inducing factors
WO1998034951A1 (en) 1997-02-11 1998-08-13 Amrad Operations Pty. Ltd. A new cytokine family and uses thereof
NZ500577A (en) 1997-04-29 2001-02-23 Regeneron Pharma Human cerberus protein that regulates cell function, induce neural development or antagonise bone morphogenic proteins
US5935852A (en) 1997-07-03 1999-08-10 Genetics Institute, Inc. DNA molecules encoding mammalian cerberus-like proteins
US6656475B1 (en) 1997-08-01 2003-12-02 The Johns Hopkins University School Of Medicine Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
CA2319703C (en) 1998-02-05 2005-09-20 The Johns Hopkins University School Of Medicine Growth differentiation factor-8
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
WO2000055193A2 (en) 1999-03-12 2000-09-21 Regeneron Pharmaceuticals, Inc. Human dan/cerberus related protein 6 (dcr6)
AU2002227172A1 (en) 2000-10-19 2002-04-29 Genaissance Pharmaceuticals, Inc. Haplotypes of the cer1 gene
WO2002054940A2 (en) 2001-01-12 2002-07-18 University Of Medicine & Dentistry Of New Jersey Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
AU2002242842A1 (en) 2001-03-23 2002-10-08 Axordia Limited Stem cell differentiation
AU2002303219A1 (en) 2001-03-30 2002-10-15 Corixa Corporation Compositions and methods for the therapy and diagnosis of cancer
GB0111004D0 (en) 2001-05-04 2001-06-27 Univ Sheffield Screening method
GB0118223D0 (en) 2001-07-26 2001-09-19 Univ Sheffield Stem loop RNA
PL373863A1 (en) 2001-10-31 2005-09-19 Alcon, Inc. Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
GB0130738D0 (en) 2001-12-21 2002-02-06 Serono Internat S A Protein
US20030134790A1 (en) 2002-01-11 2003-07-17 University Of Medicine And Dentistry Of New Jersey Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer
PL374966A1 (en) 2002-02-21 2005-11-14 Wyeth Follistatin domain containing proteins
US7193069B2 (en) 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
US20030194704A1 (en) 2002-04-03 2003-10-16 Penn Sharron Gaynor Human genome-derived single exon nucleic acid probes useful for gene expression analysis two
AU2003276430A1 (en) 2002-06-14 2003-12-31 Stowers Institute For Medical Research Wise/sost nucleic acid sequences and amino acid sequences
AR042545A1 (es) 2002-12-20 2005-06-22 Amgen Inc Agentes ligantes que inhiben la miostatina
WO2004074460A2 (en) 2003-02-19 2004-09-02 The Rockefeller University Nucleotide and protein sequences of coc genes and methods based thereon
KR100543937B1 (ko) * 2003-10-31 2006-01-23 주식회사 하이닉스반도체 데이터 출력제어회로
EP1755648A2 (en) 2004-05-27 2007-02-28 Acceleron Pharma Inc. Cerberus/coco derivatives and uses thereof

Similar Documents

Publication Publication Date Title
JP2010534684A5 (cg-RX-API-DMAC7.html)
RU2016146198A (ru) Терапевтические dll4-связывающие белки
JP2010512326A5 (cg-RX-API-DMAC7.html)
ES2563646T3 (es) Composiciones y métodos relacionados con variantes de la proteína A (SpA)
JP2013172734A5 (cg-RX-API-DMAC7.html)
JP2010532978A5 (cg-RX-API-DMAC7.html)
JP2010065037A5 (cg-RX-API-DMAC7.html)
JP2013507132A5 (cg-RX-API-DMAC7.html)
JP2009268467A5 (cg-RX-API-DMAC7.html)
JP2013538864A5 (cg-RX-API-DMAC7.html)
JP2012126742A5 (cg-RX-API-DMAC7.html)
JP2006149395A5 (cg-RX-API-DMAC7.html)
JP2010011868A5 (cg-RX-API-DMAC7.html)
JP2010088434A5 (cg-RX-API-DMAC7.html)
JP2011500073A5 (cg-RX-API-DMAC7.html)
JP2013510169A5 (cg-RX-API-DMAC7.html)
JP2014525439A5 (cg-RX-API-DMAC7.html)
JP2012519724A5 (cg-RX-API-DMAC7.html)
JP2015533791A5 (cg-RX-API-DMAC7.html)
JP2010279298A5 (cg-RX-API-DMAC7.html)
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
JP2014504297A5 (cg-RX-API-DMAC7.html)
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途
JP2007510403A5 (cg-RX-API-DMAC7.html)
JP2004532624A5 (cg-RX-API-DMAC7.html)